Severe COVID-19 disease is associated with an increase in pro-inflammatory markers, such
as IL-1, IL-6, and tumor necrosis alpha, less CD4 interferon-gamma expression, and fewer …

Abstract Treatment of the novel Coronavirus Disease 2019 (COVID-19) remains a
complicated challenge, especially among patients with severe disease. In recent studies …

Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …

Invasive fungal infections (IFIs) can complicate the clinical course of COVID-19 and are
associated with a significant increase in mortality, especially in critically ill patients admitted …

Patients with severe COVID-19, such as individuals in intensive care units (ICU), are
exceptionally susceptible to bacterial and fungal infections. The most prevalent fungal …

The aim of this study was to evaluate diagnostic means, host factors, delay of occurrence,
and outcome of patients with COVID-19 pneumonia and fungal coinfections in the intensive …

COVID-19 pandemic highlighted the complications of secondary fungal infections that
occurred globally in severe cases of coronavirus disease managed in the intensive care …

Abstract Purpose of Review Invasive fungal infections are a complication of COVID-19
disease. This article reviews literature characterizing invasive fungal infections associated …

Background: HIV-negative patients have substantial mortality from Pneumocystis jirovecii
pneumonia (PJP). We lack predictors of HIV-negative PJP-associated mortality. Objective …

Invasive fungal disease (IFD) associated with Coronavirus Disease 2019 (COVID-19) has
focussed predominantly on invasive pulmonary aspergillosis. However, increasingly …